Evidence map›Paper›PMID 28713172›Full record

ArticleEuropean polymer journal2017

POxylation as an alternative stealth coating for biomedical applications.

Herdis Bludau, Anna E Czapar, Andrzej S Pitek, Sourabh Shukla, Rainer Jordan, Nicole F Steinmetz

Abstract read
In one paragraph

Article in European polymer journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 106 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Knowledge-Based Design of Multifunctional Polymeric Nanoparticles.Handbook of experimental pharmacology · 2024
    Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Functional Polyglycidol-Based Block Copolymers for DNA Complexation.International journal of molecular sciences · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Herdis BludauChair of Macromolecular Chemistry, School of Science, Technische Unversität Dresden, Mommsenstr. 4, 01069 Dresden, Germany.
Anna E CzaparDepartment of Pathology, Case Western Reserve University, Cleveland, OH 44106, United States.
Andrzej S PitekDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH 44106, United States.
Sourabh ShuklaDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH 44106, United States.
Rainer JordanChair of Macromolecular Chemistry, School of Science, Technische Unversität Dresden, Mommsenstr. 4, 01069 Dresden, Germany.
Nicole F SteinmetzDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH 44106, United States.
Case Western Reserve University · USTU Dresden · DE

Funding

Clinical and Translational Science Collaborative of ClevelandUL1TR000439 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$50.0M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007250 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI HUANG, ALEX YEE-CHEN · 1985 to 2023
$33.4M
Clinical and Translational Science Collaborative of ClevelandTL1TR000441 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$2.8M
Engineering 'Grapevine Virus A' filaments for nanomedical applicationsR03EB020602 · NIBIB · CASE WESTERN RESERVE UNIVERSITY · PI STEINMETZ, NICOLE FRANZISKA · 2015 to 2016
$159k
NCATS NIH HHS TL1 TR000441NCATS NIH HHS UL1 TR000439NIBIB NIH HHS R03 EB020602NIGMS NIH HHS T32 GM007250
6 · The paper itself

Abstract

Polyethylene glycol (PEG) polymers are currently used in a variety of medical formulations to reduce toxicity, minimize immune interactions and improve pharmacokinetics. Despite its widespread use however, the presence of anti-PEG antibodies indicates that this polymer has the potential to be immunogenic and antigenic. Here we present an alternative polymer, poly(2-oxazoline) (POx) for stealth applications, specifically shielding of a proteinaceous nanoparticle from recognition by the immune system. Tobacco mosaic virus (TMV) was used as our testbed due to its potential for use as a nanocarrier for drug delivery and molecular imaging applications.

Indexed as

BiomaterialNanomedicinePolymer-conjugatesPolyoxazolineStealth coatingsTobacco mosaic virus

Identifiers

PMID28713172
PMCPMC5510027
OpenAlexW2547204128

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.